![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ![]() CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1989 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US | |
Employees | Employees 12 | Employees 1,40231% increase | Employees 393 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.3 b | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $943.7m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income N/A | Net income ($381.4m) (FY, 2025) | Net income ($581.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 845k | Total funding raised N/A | Total funding raised $ 127m |

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company